Serious infection after acute myocardial infarction: incidence, clinical features, and outcomes

Adriano A M Truffa1, Christopher B Granger, Kyle R White

  • 1Duke Clinical Research Institute and the Department of Medicine, Duke University Medical Center, 2400 Pratt Street, Durham, NC 27705, USA.

Abstract

Insights

Serious infections in ST-segment elevation myocardial infarction (STEMI) patients are uncommon but significantly increase the risk of death or death/myocardial infarction within 90 days. Early identification and infection prevention strategies are crucial.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Clinical Research

Background:

  • Limited understanding of infection characteristics and outcomes in ST-segment elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention.
  • Need for data on infection incidence, causes, and impact on patient prognosis post-STEMI treatment.

Purpose of the Study:

  • To investigate the incidence, characteristics, and clinical outcomes of serious infections in STEMI patients from the APEX-AMI trial.
  • To assess the association between serious infections and 90-day mortality or the composite endpoint of death/myocardial infarction.

Main Methods:

  • Analysis of 5,745 STEMI patients from the APEX-AMI trial database.
  • Detailed collection and description of infection data, including organism and location.
  • Cox proportional hazards models used to evaluate 90-day outcomes, adjusting for clinical variables and treating infection as a time-dependent covariate.

Main Results:

  • Serious infections occurred in 2.4% of patients, primarily bloodstream infections caused by Staphylococcus aureus.
  • Patients with infections had more comorbidities and lower procedural success rates.
  • Serious infection was significantly associated with increased 90-day mortality (aHR 5.6) and death/MI (aHR 4.9).

Conclusions:

  • Infections are infrequent but severely impact 90-day outcomes in STEMI patients.
  • Highlights the need for early identification of high-risk patients and development of infection-reducing strategies.

Related Concept Videos

Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Endocarditis I: Introduction01:25

Endocarditis I: Introduction

Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...